Approval programs & pathways
2 programs · 2 pathwaysExpedited / special pathways
Fast TrackRolling ReviewOrphan DrugConditional Approval
Fast TrackExpedited
Fast-track authorisation for serious diseases.
Eligibility · Serious disease + benefit
Orphan DrugOrphan
Orphan-drug status incentives.
Eligibility · Rare disease
Submission pathways · illustrative timelines & fees
CTA1 mo
Biologics · Agency fee
Clinical trial authorisation in Switzerland.
MAA13 mo
Small molecules · Agency fee
Marketing authorisation application.